Five stocks witnessing long Built-up
Five stocks witnessing long Built-up

Five stocks witnessing long Built-up

Ganesh Pawar Article rating: 3.9

The market opened in green on April 6, 2021, overall volumes in futures & options currently stand at 3,08,42,118 contracts with a turnover of Rs. 29,68,150.27 crore.

Five stocks witnessing short Built-up
Five stocks witnessing short Built-up

Five stocks witnessing short Built-up

Ganesh Pawar Article rating: 3.6

The market opened in green on April 6, 2021, overall volumes in futures & options currently stand at 3,08,42,118 contracts with a turnover of Rs. 29,68,150.27 crore.

Markets near days high; Put addition in Nifty 14,500-14,600 strikes
Markets near days high; Put addition in Nifty 14,500-14,600 strikes

Markets near days high; Put addition in Nifty 14,500-14,600 strikes

Karan Dsij Article rating: 4.6

The advance-decline ratio is quite strong, and all the sectoral indices were trading in green with Nifty Metal and Nifty Pharma being the top gainers.  On the Options’ front, the Put addition is seen in Nifty on 14,500 PE and 14,600 PE by 9.4 lakhs and 9.65 lakhs, respectively. 

Stocks that are likely to record significant movement on bourses today
Stocks that are likely to record significant movement on bourses today

Stocks that are likely to record significant movement on bourses today

Karan Dsij Article rating: 4.0

HDFC: The bank has invested in 3,88,303 equity shares of Rs 10 each of Kerala Infrastructure Fund Management Limited, representing 9.90 per cent of its share capital issued on a private placement basis.

Top 5 gainers & losers of BSE 500 in 2021 so far
Top 5 gainers & losers of BSE 500 in 2021 so far

Top 5 gainers & losers of BSE 500 in 2021 so far

Apurva Joshi Article rating: 4.3

So far in the year 2021, BSE Sensex has given a return of 4.77 per cent by closing at 50,029.83 on April 1, 2021 as against 47,751.33 as of December 31, 2020. 

In interaction with Dr Ramesh Chandra Mansukhani, Chairman of Man Industries India Ltd
In interaction with Dr Ramesh Chandra Mansukhani, Chairman of Man Industries India Ltd

In interaction with Dr Ramesh Chandra Mansukhani, Chairman of Man Industries India Ltd

Geyatee Deshpande Article rating: 4.0

Speaking with DSIJ, Dr Ramesh Chandra Mansukhani, Chairman of Man Industries India Ltd believes that Man Industries is better-placed in comparison to its peers when it comes to weather the current unprecedented situation & challenges to take advantage of pipe demand globally as well as in the domestic market

Zydus takes a step forward in treating COVID-19
Zydus takes a step forward in treating COVID-19

Zydus takes a step forward in treating COVID-19

Shreya Chaware Article rating: 2.8

On Monday, Cadila Healthcare announced that its subsidiary, Zydus Wellness Limited has obtained DCGI approval for the use of Pegylated Interferon Alpha-2b in treating COVID-19. Higher clinical improvement is shown by the Phase III clinical trials with Pegylated Interferon Alpha-2b in COVID-19. 

RSS
First19131914191519161918192019211922Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR